1:11-cv-01077 - Novartis International Pharmaceutical Ltd et al. v. Actavis Inc et al.

Detail

Case Number

1:11-cv-01077

Current Status

closed

Cause of Action

Infringement

Related Case(s)

1:10-cv-00916

1:11-cv-01112

1:12-cv-00778

1:13-cv-00052

1:13-cv-00370

1:13-cv-00371

1:13-cv-00527

1:13-cv-01467

1:14-cv-00111

1:14-cv-00777

1:14-cv-00843

1:14-cv-01104

2015-1120

2015-1121

Court

Delaware District Court

Plaintiff(s)

Novartis International Pharmaceutical Ltd

Novartis Pharmaceuticals Corp

Novartis AG

Lts Lohmann Therapie Systeme GMBH & Co KG

Novartis Pharma GMBH

Operating Company

Defendant(s)

Actavis Inc

Par Pharmaceutical Inc

Watson Laboratories Inc

Watson Pharmaceuticals Inc

Watson Pharma Pvt Ltd

Judge

Richard G. Andrews

Filing Date

2011-11-03

Termination Date

2014-09-17

Not a member? Sign up for free!
Dockets
Text
Complaint for patent infringement.
FINAL JUDGMENT (CASE CLOSED). Signed by Judge Richard G. Andrews on 9/17/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 09/17/2014)
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 434 Notice of Cross Appeal, filed by Par Pharmaceutical Inc.. USCA Case Number 15-1120. (nms) (Entered: 10/30/2014)
Please see the attached document for more details (06/18/2014)
Please see the attached document for more details(08292014)
Summons Issued with Magistrate Consent Notice attached as to Actavis Inc. on 11/4/2011; Actavis South Atlantic LLC on 11/4/2011. (dzs) (Entered: 11/04/2011)
UPDATED CIVIL DOCKET
SO ORDERED, re (84 in 1:13-cv-01467-RGA, 427 in 1:11-cv-01077-RGA) STIPULATION To Extend Time to Submit Proposed Final Judgment to September 16, 2014, filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 9/15/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 09/15/2014)
MOTION for Pro Hac Vice Appearance of Attorney Filko Prugo - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Verification- Filko Prugo)(Silver, Daniel) (Entered: 01/03/2012)
MOTION for Pro Hac Vice Appearance of Attorney Christopher Loh - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Verification- Christopher Loh)(Silver, Daniel) (Entered: 01/03/2012)
MOTION for Pro Hac Vice Appearance of Attorney Charlotte Jacobsen - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Verification of Charlotte Jacobsen)(Silver, Daniel) (Entered: 01/12/2012)
PROPOSED ORDER for Scheduling Order by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Letter to Judge Robinson regarding scheduling order)(Silver, Daniel) (Entered: 02/15/2012)
Joint PROPOSED ORDER Stipulated Protective Order by Actavis Inc., Actavis South Atlantic LLC, LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Enclosure Letter to the Honorable Sue L. Robinson from Daniel M. Silver, Esq. Regarding Disputed Provisions in Stipulated Protective Order)(Silver, Daniel) (Entered: 03/02/2012)
SEALED MOTION for Leave to File Amended Complaint for Patent Infringement - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Rule 7.1.1 Certificate, # 2 Text of Proposed Order, # 3 Exhibit 1- Amended Complaint, # 4 Exhibits A - D to Amended Complaint, # 5 Exhibit 2- Redline Version of Amended Complaint)(Silver, Daniel) (Entered: 06/21/2012)
SEALED Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding status conference on June 25, 2012. (Attachments: # 1 Exhibits 1 - 3)(Silver, Daniel) Modified on 6/21/2012 (nms). (Entered: 06/21/2012)
SEALED Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding in response to Defendants letter to the Court dated June 21, 2012 - re 69 Letter,. (Attachments: # 1 Exhibit 1-6)(Silver, Daniel) (Entered: 06/27/2012)
REDACTED VERSION of 67 Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1 - 3)(Silver, Daniel) (Entered: 06/28/2012)
REDACTED VERSION of 66 SEALED MOTION for Leave to File Amended Complaint for Patent Infringement by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 7.1.1 Certification, # 2 Text of Proposed Order, # 3 Exhibit 1 - Amended Complaint, # 4 Exhibits A - D to Amended Complaint, # 5 Exhibit 2 - Redlined Complaint)(Silver, Daniel) (Entered: 06/28/2012)
MOTION for Pro Hac Vice Appearance of Attorney Cassandra A. Adams - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification of pro hac vice)(Silver, Daniel) (Entered: 06/29/2012)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,602,176. (Attachments: # 1 Stipulation and Order of Dismissal)(nms) (Entered: 07/03/2012)
REDACTED VERSION of 73 Letter to the Honorable Richard G. Andrews by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1-6)(Silver, Daniel) (Entered: 07/05/2012)
NOTICE OF SERVICE Of Subpoena to Be Served upon Steven Dinh by Actavis Inc., Actavis South Atlantic LLC, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Gattuso, Dominick) Modified on 7/18/2012 (nms). (Entered: 07/17/2012)
SEALED DECLARATION of Christopher E. Loh re 102 Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1 to 5)(Silver, Daniel) Modified on 7/24/2012 (nms). (Entered: 07/23/2012)
NOTICE OF SERVICE of Subpoena to be served upon Steven Dinh c/o Steve Kenyon by Actavis Inc., Actavis South Atlantic LLC, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Gattuso, Dominick) (Entered: 08/01/2012)
NOTICE OF SERVICE of a Subpoena and Cross-Notice of Deposition of Dr. Steven Dinh by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A)(Silver, Daniel) (Entered: 08/10/2012)
MOTION to Modify Protective Order - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 7.1.1 Certification, # 2 Proposed Order)(Silver, Daniel) Modified on 8/20/2012 (nms). (Entered: 08/17/2012)
SEALED DECLARATION re 124 Opening Brief in Support, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1 - 7)(Silver, Daniel) Modified on 8/20/2012 (nms). (Entered: 08/17/2012)
MOTION for Pro Hac Vice Appearance of Attorney Daniel J. Minion - filed by LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Certification for Pro Hac Motion)(Silver, Daniel) (Entered: 08/24/2012)
REDACTED VERSION of 125 Declaration, of Christopher E. Loh by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Redacted Exhibits 1 - 7)(Silver, Daniel) (Entered: 08/24/2012)
NOTICE to Take Deposition of Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG and Novartis International Pharmaceutical Ltd. on October 8, 2012 by Actavis Inc., Actavis South Atlantic LLC. (Attachments: # 1 Schedule A)(Gattuso, Dominick) (Entered: 09/10/2012)
NOTICE to Take Deposition of LTS Lohmann Therapie-Systeme AG on October 10, 2012 by Actavis Inc., Actavis South Atlantic LLC. (Attachments: # 1 Schedule A)(Gattuso, Dominick) (Entered: 09/10/2012)
Supplemental DECLARATION of Christopher E. Loh re 138 Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 8)(Silver, Daniel) Modified on 9/14/2012 (nms). (Entered: 09/14/2012)
REDACTED VERSION of 139 Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 8)(Silver, Daniel) (Entered: 09/21/2012)
SEALED NOTICE of Subpoena to Henkel Corporation to Produce Documents, Information, or Objects or to Permit Inspection of Premises by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Squire, Monte) Modified on 10/22/2012 (nms). (Entered: 10/19/2012)
[SEALED] Letter to The Honorable Richard G. Andrews from Dominick T. Gattuso, Esquire regarding November 7 Discovery Hearing. (Attachments: # 1 Exhibits 1-10, # 2 Certificate of Service)(Gattuso, Dominick) (Entered: 11/05/2012)
[SEALED] Letter to The Honorable Richard G. Andrews from Melanie K. Sharp, Esquire regarding Disputeds regarding Deficiencies in Plaintiffs Responses to Watsons Discovery Requests. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Certificate of Service)(Sharp, Melanie) (Entered: 11/05/2012)
[SEALED] Letter to The Honorable Richard G. Andrews from Dominick T. Gattuso, Esquire regarding pending discovery dispute. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Gattuso, Dominick) (Entered: 11/06/2012)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver regarding discovery issues raised in Actaviss November 5, 2012 letter to the Court - re 165 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Silver, Daniel) (Entered: 11/06/2012)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding discovery issues raised in Watsons November 5, 2012 letter to the Court - re 166 Letter,. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Certificate of Service)(Silver, Daniel) (Entered: 11/06/2012)
[SEALED] Letter to The Honorable Richard G. Andrews from Melanie K. Sharp, Esquire regarding Request for Ruling on Plaintiffs Production of Documents - re 166 Letter,. (Attachments: # 1 Certificate of Service)(Sharp, Melanie) (Entered: 11/12/2012)
REDACTED VERSION of 170 Letter, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Certificate of Service)(Silver, Daniel) (Entered: 11/13/2012)
REDACTED VERSION of 169 Letter, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Silver, Daniel) (Entered: 11/13/2012)
REDACTED VERSION of 165 Letter by Actavis Inc., Actavis South Atlantic LLC. (Attachments: # 1 Exhibits 1-10)(Gattuso, Dominick) (Entered: 11/13/2012)
REDACTED VERSION of 168 Letter by Actavis Inc., Actavis South Atlantic LLC. (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 11/15/2012)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding Watsons November 12th letter to the Court - re 176 Letter. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 11/15/2012)
[SEALED] OBJECTIONS by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. to 183 Notice of Deposition Under Fed. R. Civ. P. 30(b)(6(. (Attachments: # 1 Certificate of Service)(Vrana, Robert) Modified on 11/26/2012 (nms). (Entered: 11/21/2012)
MOTION to Substitute Party Par Pharmaceutical, Inc. to replace Actavis South Atlantic LLC and Actavis Inc. - filed by Actavis Inc., Actavis South Atlantic LLC. (Attachments: # 1 Proposed Order)(Gattuso, Dominick) Modified on 1/8/2013 (nms). (Entered: 01/03/2013)
[SEALED] APPENDIX re 224 Joint Claim Construction Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 1-15, # 2 16-23)(Silver, Daniel) Modified on 5/7/2013 (nms). (Entered: 05/06/2013)
REDACTED VERSION of 225 Joint Appendix, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-16, # 2 Exhibits 17-23)(Silver, Daniel) Modified on 5/14/2013 (nms). (Entered: 05/13/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding discovery conference. (Attachments: # 1 Exhibit 1-10, # 2 Certificate of Service)(Silver, Daniel) (Entered: 05/16/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Steven J. Fineman responding to 229 letter regarding the discovery hearing. (Attachments: # 1 Exhibits A-C, # 2 Certificate of Service)(Fineman, Steven) Modified on 5/17/2013 (nms). (Entered: 05/17/2013)
REDACTED VERSION of 229 Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1 - 10)(Silver, Daniel) (Entered: 05/23/2013)
REDACTED VERSION of 231 Letter, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits A-C)(Fineman, Steven) Modified on 5/28/2013 (nms). (Entered: 05/24/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding Markman hearing. (Attachments: # 1 Exhibit, # 2 Certificate of Service)(Silver, Daniel) (Entered: 06/12/2013)
MOTION to Preclude Dr. Martyn C. Davies From Testifying - filed by Par Pharmaceutical Inc.. (Attachments: # 1 Proposed Order, # 2 7.1.1 Certification )(Fineman, Steven) Modified on 7/9/2013 (nms). (Entered: 07/08/2013)
[SEALED] DECLARATION of Jennifer Koh re 251 MOTION to Preclude Dr. Martyn C. Davies From Testifying, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits 1-8, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 11, # 5 Exhibit 12, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 16, # 10 Exhibit 17, # 11 Exhibit 18, # 12 Exhibit 19, # 13 Exhibit 20, # 14 Exhibit 21)(Fineman, Steven) Modified on 7/9/2013 (nms). (Entered: 07/08/2013)
REDACTED VERSION of 253 Declaration of Jennifer Koh, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits 1-21)(Fineman, Steven) Modified on 7/16/2013 (nms). (Entered: 07/15/2013)
MOTION for Pro Hac Vice Appearance of Attorney Brett A. Postal - filed by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Certification)(Vrana, Robert) (Entered: 07/29/2013)
[SEALED] DECLARATION of Christopher E. Loh re 263 Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-8)(Silver, Daniel) Modified on 8/5/2013 (nms). (Entered: 08/01/2013)
REDACTED VERSION of 264 Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-8)(Silver, Daniel) (Entered: 08/08/2013)
[SEALED] Joint Pretrial Order by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-14, # 2 Certificate of Service)(Silver, Daniel) Modified on 8/14/2013 (nms). (Entered: 08/12/2013)
[SEALED] DECLARATION of Jennifer Koh re 270 Reply Brief, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 22)(Lester, Katharine) Modified on 8/16/2013 (nms). (Entered: 08/15/2013)
REDACTED VERSION of 269 Joint Proposed Pretrial Order, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-14, # 2 Certificate of Service)(Silver, Daniel) Modified on 8/20/2013 (nms). (Entered: 08/19/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Melanie K. Sharp regarding Defendants position on testimony of Dr. Arthur H. Kibbe as requested by the Court. (Attachments: # 1 Exhibit 1-8)(Sharp, Melanie) (Entered: 08/20/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver responding to 278 Defendants August 20, 2013 Letter. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 8/22/2013 (nms). (Entered: 08/21/2013)
Letter to THe Honorable Richard G. Andrews from Melanie K. Sharp, Esquire regarding Response to Plaintiffs August 21, 2013 letter - re 279 Letter, 278 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Sharp, Melanie) (Entered: 08/22/2013)
MOTION for Pro Hac Vice Appearance of Attorney Michelle R. Ma - filed by Par Pharmaceutical Inc.. (Attachments: # 1 Certification of Michelle R. Ma)(Fineman, Steven) (Entered: 08/22/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Melanie K. Sharp regarding Defendants submission on Closure of Courtroom During Trial. (Attachments: # 1 Exhibit A)(Sharp, Melanie) (Entered: 08/23/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Steven J. Fineman regarding closure of the courtroom - re 283 Letter. (Attachments: # 1 Certificate of Service)(Fineman, Steven) (Entered: 08/23/2013)
REDACTED VERSION of 283 Sealed Letter, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc.. (Attachments: # 1 Exhibit A)(Sharp, Melanie) Modified on 8/23/2013 (nms). (Entered: 08/23/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Robert M. Vrana, Esquire enclosing Defendants Markman Hearing Slides. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Vrana, Robert) Modified on 8/26/2013 (nms). (Entered: 08/24/2013)
REDACTED VERSION of 289 Letter, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(Vrana, Robert) Modified on 8/26/2013 (nms). (Entered: 08/24/2013)
REDACTED VERSION of 271 Declaration of Jennifer Koh, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 22)(Fineman, Steven) Modified on 8/27/2013 (nms). (Entered: 08/26/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Steven J. Fineman regarding Courts order of August 26, 2013 - re 293 Order,. (Attachments: # 1 Certificate of Service)(Fineman, Steven) (Entered: 08/28/2013)
REDACTED VERSION of 279 Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 08/28/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding status of stay - re 296 Letter. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/13/2013)
REDACTED VERSION of 304 Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/20/2013)
[SEALED] Opening Post-Trial Brief Concerning Infringement, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 9/30/2013 (nms). (Entered: 09/27/2013)
[SEALED] MOTION to Redact Trial Transcripts - filed by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Vrana, Robert) Modified on 10/16/2013 (nms). (Entered: 10/15/2013)
[SEALED] POST TRIAL Responsive Brief on Non-Infringement, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Certificate of Service)(Vrana, Robert) Modified on 10/28/2013 (nms). (Entered: 10/25/2013)
[SEALED] POST Trial Reply Brief Concerning Infringement, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 11/12/2013 (nms). (Entered: 11/08/2013)
Motion to Deconsolidate Cases - filed by Actavis, Inc.. (Attachments: # 1 Rule 7.1.1 Certification)(Higgins, James) Modified on 12/17/2013 (nms). (Entered: 12/16/2013)
[SEALED] ANSWERING BRIEF in Opposition re 328 Motion to Deconsolidate Cases, filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.Reply Brief due date per Local Rules is 1/21/2014. (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Silver, Daniel) Modified on 1/10/2014 (nms). (Entered: 01/09/2014)
MOTION for Sanctions - filed by Par Pharmaceutical Inc.. (Attachments: # 1 Text of Proposed Order)(Fineman, Steven) (Entered: 01/10/2014)
[SEALED] DECLARATION of Jennifer Koh re 333 MOTION for Sanctions, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits A-D)(Fineman, Steven) Modified on 1/13/2014 (nms). (Entered: 01/10/2014)
[SEALED] DECLARATION of Lawrence M. Brown re 333 MOTION for Sanctions, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-14, # 3 Exhibit 15-20, # 4 Exhibit 21-23, # 5 Exhibit 24-25, # 6 Exhibit 26-28, # 7 Exhibit 29-30, # 8 Exhibit 31-34, # 9 Exhibit 35-40, # 10 Exhibit 41-45, # 11 Exhibit 46-50, # 12 Exhibit 51-55, # 13 Exhibit 56-59, # 14 Exhibit 60-66)(Fineman, Steven) Modified on 1/13/2014 (nms). (Entered: 01/10/2014)
REDACTED VERSION of 332 Answering Brief in Opposition, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A)(Silver, Daniel) Modified on 1/16/2014 (nms). (Entered: 01/16/2014)
REDACTED VERSION of 337 Declaration of Lawrence M. Brown, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits 1-66)(Lester, Katharine) Modified on 1/21/2014 (nms). (Entered: 01/17/2014)
REDACTED VERSION of 336 Declaration of Jennifer Koh, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits A-D)(Lester, Katharine) Modified on 1/21/2014 (nms). (Entered: 01/17/2014)
[SEALED] ANSWERING BRIEF in Opposition re 333 MOTION for Sanctions, filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.Reply Brief due date per Local Rules is 2/6/2014. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 1/28/2014 (nms). (Entered: 01/27/2014)
[SEALED] DECLARATION of Peter Waibel re 345 Answering Brief in Opposition, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-9, # 3 Exhibits 10-12, # 4 Exhibits 13-21, # 5 Exhibits 22-23, # 6 Certificate of Service)(Silver, Daniel) Modified on 1/28/2014 (nms). (Entered: 01/27/2014)
[SEALED] DECLARATION of Charlotte Jacobsen re 345 Answering Brief in Opposition, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibits 1-9, # 2 Certificate of Service)(Silver, Daniel) Modified on 1/28/2014 (nms). (Entered: 01/27/2014)
REDACTED VERSION of 347 Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1-9)(Silver, Daniel) (Entered: 02/03/2014)
[SEALED] Supplemental DECLARATION of Jennifer Koh re 352 Reply Brief, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits E-F)(Fineman, Steven) Modified on 2/7/2014 (nms). (Entered: 02/06/2014)
[SEALED] Unopposed Motion to Seal Limited Portions of the Transcript from the December 18, 2013 Conference - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A)(Silver, Daniel) Modified on 3/7/2014 (nms). (Entered: 03/06/2014)
REDACTED VERSION of 359 Unopposed Motion to Seal Limited Portions of the Transcript from the December 18, 2013 Conference by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A)(Silver, Daniel) (Entered: 03/14/2014)
Letter to The Honorable Richard G. Andrews from Steven J. Fineman regarding schedule for submission of pretrial order. (Attachments: # 1 Exhibit 1)(Fineman, Steven) (Entered: 03/25/2014)
Letter to Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Exchange and Filing of Pretrial Materials. (Attachments: # 1 Proposed Order)(Silver, Daniel) (Entered: 03/25/2014)
MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification by Counsel for Dominick A. Conde)(Silver, Daniel) (Entered: 04/10/2014)
[SEALED] Proposed Joint Pretrial Order, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13)(Silver, Daniel) Modified on 4/16/2014 (nms). (Entered: 04/16/2014)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Plaintiffs Response Letter to the Courts Instructions at the April 18, 2014 Pretrial Conference. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 04/22/2014)
REDACTED VERSION of 374 Proposed Joint Pretrial Order, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, 7 & 8, # 7 Exhibit 9, # 8 Exhibit 10, # 9 Exhibit 11, # 10 Exhibit 12, # 11 Exhibit 13)(Silver, Daniel) Modified on 4/24/2014 (nms). (Entered: 04/23/2014)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Plaintiffs Request Leave. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Certificate of Service)(Silver, Daniel) (Entered: 04/28/2014)
[SEALED] DECLARATION re 380 Letter, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 4/29/2014 (nms). (Entered: 04/28/2014)
REDACTED VERSION of (380 in 1:11-cv-01077-RGA, 44 in 1:13-cv-01467-RGA) Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Certificate of Service)(Silver, Daniel) (Entered: 05/05/2014)
REDACTED VERSION of (46 in 1:13-cv-01467-RGA, 382 in 1:11-cv-01077-RGA) Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 05/05/2014)
NOTICE of Petition for Inter Partes Review of the Patents-In-Suit Before the Patent Trial and Appeal Board by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Silver, Daniel) (Entered: 05/08/2014)
NOTICE of Petition for Inter Partes Review of the Patent-In-Suit Before the Patent Trial and Appeal Board (as it Pertains to the Par Matter) by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Attachments: # 1 Exhibit A)(Silver, Daniel) (Entered: 05/09/2014)
[SEALED] Opening Post-Trial Brief Concerning Infringement, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 5/27/2014 (nms). (Entered: 05/23/2014)
NOTICE of Subsequent Authority in Support of Opening Post-Trial Brief on Invalidity by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit A)(Fineman, Steven) Modified on 6/10/2014 (nms). (Entered: 06/05/2014)
Unopposed MOTION to Redact 399 Transcript and 398 Transcript - filed by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit B, # 2 Proposed Order, # 3 7.1.1 Certification)(Fineman, Steven) Modified on 6/10/2014 (nms). (Entered: 06/06/2014)
[SEALED] Reply Post-Trial Brief Concerning Infringement, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Silver, Daniel) Modified on 6/23/2014 (nms). (Entered: 06/20/2014)
NOTICE of Subsequent Authority in Support of 418 Post-Trial Briefing on Invalidity by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit A)(Fineman, Steven) Modified on 7/30/2014 (nms). (Entered: 07/29/2014)
PROPOSED Final Judgment, by Par Pharmaceutical Inc.. (Attachments: # 1 Letter)(Fineman, Steven) Modified on 9/17/2014 (nms). (Entered: 09/16/2014)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,316,023 B1; 6,335,031 B1. (Attachments: # 1 Judgment)(nms) (Entered: 09/17/2014)
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dmp, ) (Entered: 11/04/2011)
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/21/2011. Date of Expiration of Patent: 02/11/2014 for 5,602,176, 01/08/2019 for 6,316,023 B1 and 6,335,031 B1.Thirty Month Stay Deadline: 3/21/2014. (dmp, ) (Entered: 11/04/2011)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,602,176; 6,316,023 B1; 6,335,031 B1;. (dmp, ) (Entered: 11/04/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis AG. (dmp, ) (Entered: 11/04/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (dmp, ) (Entered: 11/04/2011)
Disclosure Statement pursuant to Rule 7.1 filed by LTS Lohmann Therapie-Systeme AG. (dmp, ) (Entered: 11/04/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (dmp, ) (Entered: 11/04/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis International Pharmaceutical Ltd. identifying Corporate Parent Novartis AG for Novartis International Pharmaceutical Ltd.. (dmp, ) (Entered: 11/04/2011)
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. Actavis Inc. served on 11/10/2011, answer due 12/1/2011. (Silver, Daniel) (Entered: 11/11/2011)
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. Actavis South Atlantic LLC served on 11/10/2011, answer due 12/1/2011. (Silver, Daniel) (Entered: 11/11/2011)
NOTICE of Appearance by Dominick T. Gattuso on behalf of Actavis Inc., Actavis South Atlantic LLC (Gattuso, Dominick) (Entered: 12/01/2011)
ANSWER to 1 Complaint, ACTAVIS SOUTH ATLANTIC LLCS AND ACTAVIS, INC.S ANSWERS AND COUNTERCLAIMS TO PLAINTIFFS COMPLAINT FOR PATENT INFRINGEMENT, COUNTERCLAIM against All Plaintiffs by Actavis South Atlantic LLC, Actavis Inc..(Gattuso, Dominick) (Entered: 12/01/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Actavis Inc. identifying Corporate Parent Actavis Group PTC ehf for Actavis Inc... (Gattuso, Dominick) (Entered: 12/06/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Actavis South Atlantic LLC identifying Corporate Parent Actavis, Inc. for Actavis South Atlantic LLC.. (Gattuso, Dominick) (Entered: 12/06/2011)
MOTION for Pro Hac Vice Appearance of Attorney Stephen M. Hash, Erin A. Thomson and Andrea M. Houston - filed by Actavis Inc., Actavis South Atlantic LLC. (Gattuso, Dominick) (Entered: 12/06/2011)
MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 12/08/2011)
Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 1/10/2012 at 09:00 AM before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 12/19/2011. (nmf) (Entered: 12/19/2011)
ANSWER to 13 Answer to Complaint, Counterclaim,, PLAINTIFFS REPLY TO DEFENDANTS COUNTERCLAIMS by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 12/22/2011)
Joint PROPOSED ORDER Proposed Case Scheduling Order by Actavis Inc., Actavis South Atlantic LLC, LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/08/2012)
NOTICE OF SERVICE of (1) Plaintiffs First Set of Requests to Actavis for the Production of Documents and Things and (2) Plaintiffs First Set of Interrogatories to Actavis by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/10/2012)
NOTICE OF SERVICE of Plaintiffs Rule 26(a)(1) Initial Disclosures and Notice of Service by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/23/2012)
NOTICE OF SERVICE of Defendants Actavis South Atlantic LLC and Actavis, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. Rule 26(a)(1) and D. Del. LR 16.2 by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 01/23/2012)
NOTICE OF SERVICE of Plaintiffs Second Set of Requests to Actavis for the Production of Documents and Things by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/26/2012)
NOTICE OF SERVICE of DEFENDANTS ACTAVIS SOUTH ATLANTIC LLC AND ACTAVIS, INC.S FIRST SET OF REQUESTS FOR PRODUCTION AND ACTAVIS SOUTH ATLANTIC LLC AND ACTAVIS, INC.S FIRST SET OF INTERROGATORIES by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 02/09/2012)
NOTICE OF SERVICE of ACTAVISS RESPONSES AND OBJECTIONS TO PLAINTIFFS FIRST SET OF REQUESTS TO ACTAVIS FOR THE PRODUCTION OF DOCUMENTS AND THINGS AND ACTAVISS RESPONSES AND OBJECTIONS TO PLAINTFFS FIRST SET OF INTERROGATORIES TO ACTAVIS by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 02/09/2012)
NOTICE OF SERVICE of Defendants Actavis South Atlantic LLC and Actavis, Inc.s Disclosures Pursuant to Rules 3(c) and 5(b) of the District of Delawares Default Standard for Discovery by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 02/17/2012)
NOTICE OF SERVICE of Plaintiffs ESI Disclosures Pursuant to Delaware Default Standards 3.c., 4.a. and 5.b. by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 02/17/2012)
NOTICE OF SERVICE of Defendants Actavis South Atlantic LLC and Actavis, Inc.s Disclosures Pursuant to Rules 3(a) and (b) of the District of Delawares Default Standard for Discovery by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 02/21/2012)
NOTICE OF SERVICE of Plaintiffs ESI Disclosures Pursuant to D. Del. Default Standards 3.a. and 3.b. by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 02/21/2012)
SCHEDULING ORDER & CONSOLIDATION ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 11/9/2012. Amended Pleadings due by 11/9/2012. Discovery due by 3/22/2013. A Discovery Conference is set for 6/25/2012 at 04:30 PM in Courtroom 4B before Judge Sue L. Robinson. An Oral Argument is set for 7/26/2013 at 09:30 AM in Courtroom 4B before Judge Sue L. Robinson. Claim Construction Opening Brief due by 3/29/2013. Claim Construction Answering Brief due by 4/26/2013. Claim Construction Reply Brief due by 5/14/2013. A Final Pretrial Conference is set for 7/26/2013 at 09:30 AM in Courtroom 4B before Judge Sue L. Robinson. A Bench Trial is set for 8/29/2013 at 09:30 AM in Courtroom 4B before Judge Sue L. Robinson. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 11-CV-1077-SLR. Signed by Judge Sue L. Robinson on 2/22/2012. Associated Cases: 1:11-cv-01077-SLR, 1:11-cv-01112-SLR(nmf) (Entered: 02/22/2012)
STIPULATION TO EXTEND TIME to File Proposed Protective Order to March 2, 2012 - filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Caesar, Erika) (Entered: 02/23/2012)
NOTICE OF SERVICE of Initial Discovery under Paragraph 4.b of the Delaware Default Standard by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Caesar, Erika) (Entered: 02/24/2012)
NOTICE OF SERVICE of Actaviss Responses and Objections to Plaintiffs Second Requests to Actavis for the Production of Documents and Things by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 02/27/2012)
SO ORDERED re 39 Proposed Stipulated Protective Order, filed by Watson Pharma Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Novartis International Pharmaceutical Ltd., Novartis AG, Novartis Pharma AG, Actavis South Atlantic LLC, Novartis Pharmaceuticals Corporation, Watson Laboratories Inc., Watson Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 3/12/2012. (nms) (Main Document 40 replaced on 3/14/2012) (nms). (Entered: 03/12/2012)
NOTICE OF SERVICE of (1) Plaintiffs Responses to Actavis South Atlantic LLC and Actavis, Inc.s First Set of Interrogatories; (2) Plaintiffs Responses to Actaviss First Set of Requests for Production by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 03/15/2012)
MOTION for Pro Hac Vice Appearance of Attorney Derek F. Dahlgren - filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Caesar, Erika) (Entered: 03/23/2012)
ORDER Setting Teleconference : A Telephone Conference is set for 4/11/2012 at 01:30 PM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 3/27/2012. (dlk) (Entered: 03/27/2012)
NOTICE OF SERVICE of Plaintiffs Second Set of Requests to Watson for the Production of Documents and Things by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 03/30/2012)
NOTICE OF SERVICE of Plaintiffs Second Set of Interrogatories to Watson by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 04/10/2012)
ORDER Setting Teleconference : A Telephone Conference is set for 7/2/2012 at 11:00 AM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 4/12/2012. (dlk) (Entered: 04/12/2012)
NOTICE OF SERVICE of Plaintiffs Third Set of Requests to Actavis for Production of Documents and Things by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/01/2012)
NOTICE OF SERVICE of Plaintiffs Third Set of Requests to Watson for the Production of Documents and Things by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/01/2012)
NOTICE OF SERVICE of Defendants Response to Plaintiffs Second Set of Requests for the Production of Documents and Things by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 05/02/2012)
NOTICE OF SERVICE of Watsons Second Set of Interrogatories to Plaintiffs (Nos. 7-11) by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Caesar, Erika) (Entered: 05/09/2012)
SEALED NOTICE to Take Deposition of under Fed. R. Civ. P. 30(b)(6) to Actavis on May 30, 2012 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 5/14/2012 (nms). (Entered: 05/11/2012)
SEALED NOTICE to Take Deposition of under Fed. R. Civ. P. 30(b)(6) to Watson on May 31, 2012 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 5/14/2012 (nms). (Entered: 05/11/2012)
NOTICE OF SERVICE of Responses of Defendants, Watson Laboratories, Inc., Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. to Plaintiffs Second Set of Interrogatories (No. 3) by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Caesar, Erika) (Entered: 05/14/2012)
REDACTED VERSION of 51 Notice to Take Deposition, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 05/18/2012)
REDACTED VERSION of 52 Notice to Take Deposition, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 05/18/2012)
NOTICE OF SERVICE of Actavis South Atlantic LLC and Actavis, Inc.s Second Set of Requests for Production by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 05/18/2012)
SEALED OBJECTIONS by Actavis Inc., Actavis South Atlantic LLC to 51 to Take Deposition of under Fed. R. Civ. P. 30(b)(6) to Actavis on May 30, 2012.(Gattuso, Dominick) (Main Document 57 replaced on 5/29/2012) (dzs, ). Modified on 5/29/2012 (dzs, ). Modified on 5/30/2012 (nms). (Entered: 05/29/2012)
SEALED NOTICE to Take Deposition under Fed. R. Civ. P. 30(b)(6) to Actavis on June 6, 2012, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 5/31/2012 (nms). (Entered: 05/30/2012)
NOTICE OF SERVICE of Actaviss Responses and Objections to Plaintiffs Third Set of Requests to Actavis for the Production of Documents and Things by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 06/04/2012)
NOTICE OF SERVICE of Watsons Objections and Responses to Plaintiffs Third Set of Requests for the Production of Documents and Things by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Caesar, Erika) (Entered: 06/04/2012)
REDACTED VERSION of 57 Objections To Plaintiffs Novartis Pharmaceuticals Corporation, Novartis Ag, Novartis Pharma Ag, Novartis International Pharmaceutical Ltd., and Lts Lohmann Therapie-systeme Ags Notice of Deposition under Fed. R. Civ. P. 30(b)(6) to Actavis, by Actavis Inc., Actavis South Atlantic LLC. (Gattuso, Dominick) Modified on 6/5/2012 (nms). (Entered: 06/05/2012)
REDACTED VERSION of 58 Notice to Take Deposition, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 06/07/2012)
NOTICE OF SERVICE of Plaintiffs Responses to Watsons Second Set of Interrogatories (7-11) by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/11/2012)
NOTICE OF SERVICE of Supplemental Response to Plaintiffs Interrogatory No. 1 by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Caesar, Erika) (Entered: 06/11/2012)
MOTION for Pro Hac Vice Appearance of Attorney Seth Cockrum - filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Caesar, Erika) (Entered: 06/20/2012)
NOTICE OF SERVICE of Plaintiffs Responses to Actavis South Atlantic LLC and Actavis, Incs Second Set of Requests for Production by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/21/2012)
SEALED Letter to The Honorable Richard G. Andrews from Melanie K. Sharp regarding outline of issues of Defendants Watson Laboratories, Inc. Watson Pharmaceuticals, Inc., Waston Pharma, Inc., Actavis South Atlantic LLC and Actavis, Inc. to be presented at June 25, 2012 Status Conference. (Sharp, Melanie) (Entered: 06/21/2012)
REDACTED VERSION of 69 Letter, to The Honorable Richard G. Andrews from Melanie K. Sharp regarding outline of issues of Defendants to be presented at Status Conference by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Caesar, Erika) (Entered: 06/22/2012)
NOTICE OF SERVICE of Watsons Second Supplemental Response to Plaintiffs Interrogatory No. 1 by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Sharp, Melanie) (Entered: 06/25/2012)
SEALED Letter to The Honorable Richard G. Andrews from Melanie K. Sharp, Esquire regarding response to Novartis June 21, 2012 letter in anticipation of the June 29 Discovery Status Conference - re 67 Letter. (Sharp, Melanie) (Entered: 06/27/2012)
Official Transcript of Discovery Conference held on 06-29-12 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/23/2012. Redacted Transcript Deadline set for 8/1/2012. Release of Transcript Restriction set for 10/1/2012. (lad) (Entered: 07/01/2012)
NOTICE OF SERVICE of Subpoenas by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/02/2012)
SEALED EXHIBITS A - F re 78 Notice of Service of Subpoenas, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/3/2012 (nms). (Entered: 07/02/2012)
STIPULATION of Dismissal Of 176 Patent Claims and Counterclaims, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/3/2012 (nms). (Entered: 07/03/2012)
SO ORDERED re 80 Stipulation and Order of Dismissal of 176 Patent Claims and Counterclaims, filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 7/3/2012. (nms) (Entered: 07/03/2012)
NOTICE OF SERVICE of Subpoenas by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/05/2012)
SEALED EXHIBITS A and B to 83 Notice of Service, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/9/2012 (nms). (Entered: 07/05/2012)
REDACTED VERSION of 79 Exhibits A-F to a Document, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/9/2012 (nms). (Main Document 86 replaced on 7/9/2012) (nms). (Entered: 07/06/2012)
ORDER Setting Teleconference : A Telephone Conference is set for 11/5/2012 at 11:00 PM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 7/9/2012. (dlk) (Entered: 07/09/2012)
STIPULATION TO EXTEND TIME for Watson to File Response to Plaintiffs Motion for Leave to Amend Their Complaint for Patent Infringement Against Watson to July 11, 2012 - filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 07/09/2012)
REDACTED VERSION of 72 Letter to The Honorable Richard G. Andrews from Melanie K. Sharp, Esquire regarding response to Novartis June 21, 2012 letter in anticipation of the June 29 Discovery Status Conference by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 07/09/2012)
REDACTED VERSION of 84 Exhibit to a Document by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/10/2012)
SEALED ANSWERING BRIEF in Opposition re 66 SEALED MOTION for Leave to File Amended Complaint for Patent Infringement filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..Reply Brief due date per Local Rules is 7/23/2012. (Sharp, Melanie) (Entered: 07/11/2012)
NOTICE OF SERVICE of Subpoena by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/12/2012)
SEALED EXHIBIT re 92 Notice of Service of Subpoena by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/12/2012)
NOTICE OF SERVICE of Plaintiffs Initial Claim Chart for U.S. Patent No. 6,054,196 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/16/2012)
NOTICE OF SERVICE of Responses of Non-Party Pharma-Q, Inc. to Plaintiffs Rule 45 Subpoena and Responses of Non-Party Loparex, LLC to Plaintiffs Rule 45 Subpoena by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 07/16/2012)
NOTICE to Take Deposition of Paul M. Garguilo on August 28, 2012 by Actavis Inc., Actavis South Atlantic LLC, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Gattuso, Dominick) (Entered: 07/17/2012)
NOTICE to Take Deposition of Henricus L.G.M. Tiemessen on August 21, 2012 by Actavis Inc., Actavis South Atlantic LLC, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Gattuso, Dominick) (Entered: 07/17/2012)
REDACTED VERSION of 91 Answering Brief in Opposition, to Plaintiffs Motion for Leave to Amend Their Complaint for Patent Infringement by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 07/18/2012)
NOTICE OF SERVICE of Responses of Non-Party Ren-Pharm International, Ltd. to Plaintiffs Rule 45 Subpoena by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 07/18/2012)
REDACTED VERSION of 93 Exhibit to a Document by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/19/2012)
SEALED REPLY BRIEF re 66 SEALED MOTION for Leave to File Amended Complaint for Patent Infringement filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/23/2012)
SEALED DECLARATION of John M. Engel, Esquire re 102 Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/24/2012 (nms). (Entered: 07/23/2012)
REQUEST for Oral Argument by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation re 66 SEALED MOTION for Leave to File Amended Complaint for Patent Infringement. (Silver, Daniel) (Entered: 07/24/2012)
ORDER Denying 66 SEALED MOTION for Leave to File Amended Complaint for Patent Infringement. Signed by Judge Richard G. Andrews on 7/25/2012. (nms) (Entered: 07/25/2012)
NOTICE OF SERVICE of Plaintiffs Supplemental Response to Watsons Interrogatory No. 3 and Plaintiffs Supplemental Response to Watsons Interrogatory No. 11 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/25/2012)
NOTICE OF SERVICE of the Responses of Non-Party Pace Analytical Life Sciences to Plaintiffs Rule 45 Subpoena by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 07/26/2012)
NOTICE OF SERVICE of Plaintiffs Second Supplemental Response to Watsons Interrogatory No. 1 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/26/2012)
REDACTED VERSION of 102 Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/30/2012)
REDACTED VERSION of 103 Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/30/2012)
REDACTED VERSION of 104 Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/30/2012)
SEALED STIPULATION of Dismissal of Patent 176 Claims and Counterclaims, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/31/2012 (nms). (Entered: 07/30/2012)
Sealed ORDER Granting 113 Stipulation of Dismissal of Patent 176 Claims and Counterclaims, filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 8/1/2012. (nms) (Entered: 08/02/2012)
REDACTED VERSION of 113 Stipulation of Dismissal, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 08/06/2012)
REDACTED VERSION of 115 Order, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 08/06/2012)
NOTICE OF SERVICE of Plaintiffs Third Supplemental Response to Watsons Interrogatory No. 1 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/06/2012)
NOTICE OF SERVICE of Actavis South Atlantic LLC and Actavis, Inc.s Third Set of Requests for Production by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 08/08/2012)
NOTICE OF SERVICE of Watsons Second Set of Requests for the Production of Documents, ESI and Things to Plaintiffs by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 08/09/2012)
NOTICE to Take Deposition of Olivier Garinot on September 18, 2012 by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Gattuso, Dominick) (Entered: 08/16/2012)
SEALED OPENING BRIEF in Support re 123 MOTION to Modify Protective Order, filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Answering Brief/Response due date per Local Rules is 9/4/2012. (Silver, Daniel) Modified on 8/20/2012 (nms). (Entered: 08/17/2012)
NOTICE OF SERVICE of Plaintiffs Second Supplemental Responses to Actaviss Interrogatories Nos. 1 and 2 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/23/2012)
REDACTED VERSION of 124 Opening Brief in Support, of Plaintiffs Motion to Modify The Protective Order by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 08/24/2012)
NOTICE OF SERVICE of Watsons First Supplemental Response to Plaintiffs Interrogatory No. 2 by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Sharp, Melanie) (Entered: 08/27/2012)
SEALED ANSWERING BRIEF in Opposition re 123 MOTION to Modify Protective Order filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..Reply Brief due date per Local Rules is 9/14/2012. (Sharp, Melanie) (Entered: 09/04/2012)
NOTICE OF SERVICE of Plaintiffs Responses to Actaviss Third Set of Requests for Production by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/10/2012)
REDACTED VERSION of 131 Answering Brief in Opposition, by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Squire, Monte) Modified on 3/28/2014 (nms). (Entered: 09/11/2012)
NOTICE OF SERVICE of Plaintiffs Responses to Watsons Second Set of Requests for Production by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/11/2012)
NOTICE to Take Deposition of Paul M. Gargiulo on September 20, 2012 (AMENDED) by Actavis Inc., Actavis South Atlantic LLC, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Gattuso, Dominick) (Entered: 09/13/2012)
SEALED REPLY BRIEF re 123 MOTION to Modify Protective Order filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/14/2012)
NOTICE OF SERVICE of Plaintiffs Third Supplemental Responses to Actaviss Interrogatories Nos. 1 and 2 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/14/2012)
REDACTED VERSION of 138 Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/21/2012)
NOTICE OF SERVICE of Plaintiffs Objections to Defendants Notice of Rule 30(b)(6) Deposition to LTS and Plaintiffs Objections to Defendants Notice of Rule 30(b)(6) Deposition to Novartis by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/28/2012)
NOTICE OF SERVICE of (1) Actavis South Atlantic LLC Actavis, Inc.s Second Set of Interrogatories; (2) Actavis South Atlantic LLC and Actavis, Inc.s Requests for Admissions; (3) Actaviss Notice of Rule 30(b)(6) Deposition to LTS Lohmann Therapie-Systeme AG; and (4) Actaviss Supplemental Notice of Rule 30(b)(6) Deposition to Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, and Novartis International Pharmaceutical Ltd. by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 09/28/2012)
NOTICE to Take Deposition of Karen Bergmann on October 30, 2012 by Actavis Inc., Actavis South Atlantic LLC, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 09/28/2012)
NOTICE to Take Deposition of Joerg Ogorka on October 29, 2012 by Actavis Inc., Actavis South Atlantic LLC, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 09/28/2012)
NOTICE to Take Deposition of Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd. on October 31, 2012 by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 09/28/2012)
NOTICE to Take Deposition of LTS Lohmann Therapie-Systeme AG on October 31, 2012 by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 09/28/2012)
NOTICE OF SERVICE of Watsons First Set of Requests for Admission by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 10/02/2012)
NOTICE OF SERVICE of Plaintiffs Fourth Supplemental Response to Watsons Interrogatory No. 1 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 10/17/2012)
SEALED NOTICE of Filing of Return of Service of Subopena to Henkel Corporation for Production of Documents, Information, or Objects and to Permit Inspection of Premises by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. re 151 Notice (Other), (Squire, Monte) (Entered: 10/22/2012)
REDACTED VERSION of 151 Notice of Subpoena to Henkel Corporation to Produce Documents, Information, or Objects or to Permit Inspection of Premises, by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 10/26/2012 (nms). (Entered: 10/25/2012)
REDACTED VERSION of 152 Notice of Filing of Return of Service of Subopena to Henkel Corporation for Production of Documents, Information, or Objects and to Permit Inspection of Premises, by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 10/26/2012 (nms). (Entered: 10/25/2012)
Joint CLAIM Construction Statement, by Actavis Inc., Actavis South Atlantic LLC, LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Silver, Daniel) Modified on 11/1/2012 (nms). (Entered: 10/26/2012)
Joint CLAIM Construction Chart, by Actavis Inc., Actavis South Atlantic LLC, LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Silver, Daniel) Modified on 11/1/2012 (nms). (Entered: 10/26/2012)
NOTICE OF SERVICE of Plaintiffs Responses to Actaviss Requests for Admission and Plaintiffs Responses to Actaviss Second Set of Interrogatories by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 10/29/2012)
NOTICE OF SERVICE of Watsons Third Supplemental Response to Plaintiffs Interrogatory No. 1 by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 11/01/2012)
NOTICE OF SERVICE of Plaintiffs Responses to Watsons Requests for Admission by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/01/2012)
[SEALED] NOTICE to Take Deposition of ACTAVIS on November 16, 2012 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/02/2012)
[SEALED] NOTICE to Take Deposition of WATSON on November 19, 2012 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/02/2012)
NOTICE OF SERVICE of (1) LTSs Objections to Actaviss Notice of Rule 30(b)(6) Deposition to LTS; and (2) Novartiss Objections to Actaviss Supplemental Notice of Rule 30(b)(6) Deposition to Novartis by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/02/2012)
NOTICE OF SERVICE of Actavis Supplemental Responses and Objections to Plaintiffs Interrogatories to Actavis by Actavis Inc., Actavis South Atlantic LLC.(Gattuso, Dominick) (Entered: 11/05/2012)
NOTICE OF SERVICE of Plaintiffs Fourth Supplemental Responses to Actaviss Interrogatory No. 2 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/05/2012)
NOTICE OF SERVICE of Plaintiffs Fifth Supplemental Response to Watsons Interrogatory No. 1 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/05/2012)
ORDER Denying 123 MOTION to Modify Protective Order. Signed by Judge Richard G. Andrews on 11/7/2012. (nms) (Entered: 11/07/2012)
REDACTED VERSION of 160 Notice to Take Deposition by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 11/09/2012)
REDACTED VERSION of 161 Notice to Take Deposition by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 11/09/2012)
Official Transcript of Proctective Order Motion held on 11-07-12 before Judge Richard G. Andrews. Court Reporter/Transcriber Deanna Warner. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/3/2012. Redacted Transcript Deadline set for 12/13/2012. Release of Transcript Restriction set for 2/11/2013. (lad) (Entered: 11/12/2012)
REDACTED VERSION of 166 Letter to The Honorable Richard G. Andrews from Melanie K. Sharp, Esquire regarding deficiencies in responses to Watsons Discovery Requests, by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 11/13/2012 (nms). (Entered: 11/12/2012)
NOTICE of Intent to Request Redaction by Robert M. Vrana re 174 Transcript,, (Vrana, Robert) (Entered: 11/16/2012)
NOTICE OF SERVICE of Defendants Objections to Plaintiffs Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 11/16/2012)
OBJECTIONS by Actavis Inc., Actavis South Atlantic LLC to 160 Notice to Take Deposition . (Gattuso, Dominick) (Entered: 11/16/2012)
REDACTED VERSION of 176 Letter, by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 11/20/2012 (nms). (Entered: 11/19/2012)
NOTICE OF SERVICE of Opening Expert Report of Professor Alexander M. Klibanov and Opening Expert Report of Professor Martyn C. Davies on Infringement Pursuant to Fed R. Civ. P. 26(a)(2)(B) by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 11/20/2012)
NOTICE OF SERVICE of Opening Expert Report of Arthur H. Kibbe, Ph.D. by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 11/20/2012)
ORDER Denying Defendants letter request for a ruling that Plaintiffs must produce documents that describe all of Plaintiffs testing of Watsons ANDA product (see 176 Letter, and 181 Letter). Signed by Judge Richard G. Andrews on 11/21/2012. (nms) (Entered: 11/21/2012)
REDACTED VERSION of 181 Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 11/26/2012)
REDACTED VERSION of 189 Objections to Plaintiffs Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) to Watson, by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 11/27/2012 (nms). (Entered: 11/26/2012)
STIPULATION to Redact 174 Transcript of the Courts November 7, 2012 Hearing, by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 12/4/2012 (nms). (Entered: 12/03/2012)
ORDER Denying 192 STIPULATION to Redact 174 Transcript of the Courts November 7, 2012, Hearing, filed by Watson Pharma Inc., Watson Laboratories Inc., Watson Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/4/2012. (nms) (Entered: 12/04/2012)
ORDER Setting Teleconference: A Telephone Conference is set for 1/14/2013 at 10:00 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 12/12/12. (dlk) (Entered: 12/12/2012)
ORDER Granting 195 Unopposed MOTION to Substitute Party Par Pharmaceutical, Inc. to replace Actavis South Atlantic LLC and Actavis Inc., filed by Actavis Inc., Actavis South Atlantic LLC. Signed by Judge Richard G. Andrews on 1/8/2013. (nms) (Entered: 01/08/2013)
NOTICE of Appearance by Steven J. Fineman on behalf of Par Pharmaceutical Inc. (Fineman, Steven) (Entered: 01/08/2013)
NOTICE of Appearance by Jaclyn Levy on behalf of Par Pharmaceutical Inc. (Levy, Jaclyn) (Entered: 01/08/2013)
MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown, Jennifer Koh and Gina R. Gencarelli - filed by Par Pharmaceutical Inc.. (Levy, Jaclyn) (Entered: 01/08/2013)
STIPULATION TO EXTEND TIME for expert discovery and claim construction in the Scheduling Order to Rebuttal expert reports: January 25, 2013;Reply expert reports: February 28, 2013;Close of expert discovery: March 29, 2013;Parties simultaneous service of opening claim construction briefs: April 5, 2013;Parties simultaneous service of responsive claim construction briefs: April 26, 2013; andParties filing of joint claim construction brief: May 3, 2013. - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/10/2013)
NOTICE OF SERVICE of Rebuttal Expert Report of Professor Alexander M. Klibanov by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/28/2013)
NOTICE OF SERVICE of Rebuttal Expert Report of Bruce Ganem, Ph.D. by Par Pharmaceutical Inc..(Fineman, Steven) (Entered: 01/28/2013)
NOTICE OF SERVICE of Expert Report of Professor Graham Buckton by Par Pharmaceutical Inc..(Fineman, Steven) (Entered: 01/28/2013)
NOTICE OF SERVICE of Expert Report of Jonathan L. Sessler, Ph.D. by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 01/29/2013)
NOTICE of Withdrawal of Jaclyn C. Levy as Counsel by Par Pharmaceutical Inc. (Levy, Jaclyn) (Entered: 02/08/2013)
ORDER Setting Mediation Conference: A Mediation Conference is set for 4/23/2013 at 10:00 AM in Courtroom 6C before Judge Christopher J. Burke (See Order for further details and deadlines). Signed by Judge Christopher J. Burke on 2/14/2013. (dlk) (Entered: 02/14/2013)
NOTICE OF SERVICE of Plaintiffs Reply Expert Report of Professor Alexander M. Klibanov and Reply Expert Report of Professor Martyn C. Davies by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 03/01/2013)
NOTICE OF SERVICE of Reply Expert Report of Professor Graham Buckton by Par Pharmaceutical Inc..(Fineman, Steven) (Entered: 03/01/2013)
NOTICE of Appearance by Katharine Crawford Lester on behalf of Par Pharmaceutical Inc. (Lester, Katharine) (Entered: 03/05/2013)
NOTICE OF SERVICE of Rebuttal Expert Report of Arthur H. Kibbe, Ph.D. by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 03/05/2013)
NOTICE of Name Change and Supplemental Rule 7.1 Statement (C.A. 11-1112, D.I. 15) by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Vrana, Robert) (Entered: 04/01/2013)
Supplemental Disclosure Statement pursuant to Rule 7.1 filed by Watson Laboratories Inc., Watson Pharma Inc., Actavis, Inc. identifying Corporate Parent Actavis, Inc. for Watson Laboratories Inc., Watson Pharma Inc... (Vrana, Robert) (Entered: 04/03/2013)
NOTICE OF SERVICE of (1) Plaintiffs Opening Claim Construction Brief; and (2) Declaration of Christopher E. Loh by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 04/05/2013)
NOTICE OF SERVICE of Defendants Opening Claim Construction Brief by Actavis, Inc., Par Pharmaceutical Inc., Par Pharmaceutical Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 04/09/2013)
STIPULATION to Amend Scheduling Order (exchange of surreply expert reports to April 12, 2013; close of expert discovery to June 6, 2013; and Rule 26(e) supplementations to June 20, 2013) re Oral Order,,, Set Hearings,, by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 04/12/2013)
NOTICE OF SERVICE of Sur-Reply Expert Report of Professor Alexander M. Klibanov by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 04/16/2013)
NOTICE OF SERVICE of Sur-Reply Expert Report of Jonathan L. Sessler, Ph.D. by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 04/17/2013)
STIPULATION To Extend Time to File Stipulation or Other Submission(s) Regarding the Exchange of Witness Lists to April 24, 2013 - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 4/23/2013 (nms). (Entered: 04/22/2013)
STIPULATION TO EXTEND TIME To Submit A Stipulation Regarding Deadlines for Identification of Witnesses To Be Called At Trial to April 30, 2013 - filed by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 04/24/2013)
NOTICE OF SERVICE of Plaintiffs Responsive Claim Construction brief and the Supplemental Declaration of Christopher E. Loh by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 04/29/2013)
NOTICE OF SERVICE of Defendants Responsive Claim Construction Brief by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 04/29/2013)
Stipulation and Order regarding disclosure of fact witnesses to be called at trial, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Par Pharmaceutical Inc., Par Pharmaceutical Inc., Watson Laboratories Inc.. (Vrana, Robert) Modified on 5/1/2013 (nms). (Entered: 04/30/2013)
STIPULATION TO EXTEND TIME to file Joint Claim Construction Brief and Joint Appendix to Monday, May 6, 2013 - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 05/03/2013)
[SEALED] Joint Claim Construction Brief, filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 5/7/2013 (nms). (Entered: 05/06/2013)
REDACTED VERSION of 224 Joint Claim Construction Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 5/14/2013 (nms). (Entered: 05/13/2013)
NOTICE to Take Deposition of Defendants Experts on (See Notice for Details) by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/16/2013)
NOTICE to Take Deposition of Plaintiffs Experts on dates set forth in Notice by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc..(Vrana, Robert) (Entered: 05/16/2013)
NOTICE to Take Deposition of Alexander M. Klibanov (May 2nd and May 3rd) and Martyn C. Davies, Ph.D. (June 5th and June 6th) by Par Pharmaceutical Inc..(Fineman, Steven) (Entered: 05/21/2013)
Official Transcript of Discovery Dispute held on 05-20-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/17/2013. Redacted Transcript Deadline set for 6/25/2013. Release of Transcript Restriction set for 8/23/2013. (lad) (Entered: 05/25/2013)
NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.s Amended Initial Disclosures Pursuant to Fed. R. Civ. P. Rule 26(a)(1) by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/06/2013)
NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.s List of Fact Witnesses it Intends to Call at Trial by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/07/2013)
NOTICE OF SERVICE of List of Fact Witnesses to be Called at Trial in the Watson Defendants Case-In-Chief by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 06/07/2013)
NOTICE OF SERVICE of Plaintiffs Preliminary List of Fact Witnesses for Trial by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/10/2013)
NOTICE OF SERVICE of Plaintiffs Preliminary List of Rebuttal Fact Witnesses for Trial by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/14/2013)
NOTICE OF SERVICE of List of Fact Witnesses to be Called at Trial in the Watson Defendants Rebuttal Case by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 06/14/2013)
NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.s List of Rebuttal Fact Witnesses it Intends to Call at Trial by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/14/2013)
Official Transcript of Markman Hearing held on 06-13-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/8/2013. Redacted Transcript Deadline set for 7/17/2013. Release of Transcript Restriction set for 9/16/2013. (lad) (Entered: 06/16/2013)
REDACTED VERSION of 240 Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 06/19/2013)
NOTICE OF SERVICE of Plaintiffs Rule 26(e) Supplement to Par and Plaintiffs Rule 26(e) Supplement to Watson by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/20/2013)
NOTICE OF SERVICE of Par Pharmaceutical, Inc.s Third Supplemental Responses and Objections to Plaintiffs Interrogatories (Nos. 1-2) by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/20/2013)
NOTICE OF SERVICE of Supplementation of Rebuttal Expert Report and Deposition Testimony of Bruce Ganem, Ph.D. and Supplemental Expert Report of Professor Graham Buckton by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/20/2013)
NOTICE OF SERVICE of (1) Watsons Supplemental Disclosures Pursuant to Fed. R. Civ. P. 26(e), (2) Watsons Fourth Supplemental Response to Plaintiffs Interrogatory No. 1 and (3) Watsons Second Supplemental Response to Plaintiffs Interrogatory No. 2 by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 06/20/2013)
ORDER Providing Construction for Claim Terms in Dispute (see 224 Sealed Joint Claim Construction Brief). Signed by Judge Richard G. Andrews on 6/21/2013. (ksr, ) Modified on 6/25/2013 (nms). (Entered: 06/21/2013)
[SEALED] OPENING BRIEF in Support re 251 MOTION to Preclude Dr. Martyn C. Davies From Testifying, filed by Par Pharmaceutical Inc..Answering Brief/Response due date per Local Rules is 7/25/2013. (Fineman, Steven) Modified on 7/9/2013 (nms). (Entered: 07/08/2013)
Stipulation Regarding the Ownership of the Patents-In-Suit, by Actavis, Inc., LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Par Pharmaceutical Inc., Par Pharmaceutical Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 7/9/2013 (nms). (Entered: 07/09/2013)
REDACTED VERSION of 252 Opening Brief in Support, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 7/16/2013 (nms). (Entered: 07/15/2013)
NOTICE of Withdrawal of Certain Pro Hac Vice Counsel - Derek F. Dahlgren, Esquire by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Vrana, Robert) (Entered: 07/17/2013)
MOTION for Pro Hac Vice Appearance of Attorney Roger J. Chin - filed by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 07/24/2013)
STIPULATION TO EXTEND TIME for Plaintiffs to file their Opposition to Pars Daubert Motion and the deadline for Par to file a Reply Brief in support of its Daubert Motion to August 1, 2013 and August 12, 2013, respectively - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 07/25/2013)
NOTICE OF SERVICE of Defendants Notice Pursuant to 35 U.S.C. §282 by Actavis, Inc., Par Pharmaceutical Inc., Par Pharmaceutical Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 07/26/2013)
[SEALED] ANSWER BRIEF re 251 MOTION to Preclude, filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 8/5/2013 (nms). (Entered: 08/01/2013)
NOTICE OF SERVICE re 263 Reply Brief and 264 Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 8/5/2013 (nms). (Entered: 08/02/2013)
REDACTED VERSION of 263 Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 08/08/2013)
STIPULATION TO EXTEND TIME to file Reply Brief re 251 Daubert Motion - filed by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 8/14/2013 (nms). (Entered: 08/12/2013)
[SEALED] REPLY BRIEF re 251 MOTION to Preclude Certain Testimony of Dr. Martyn C. Davies, filed by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 8/16/2013 (nms). (Entered: 08/15/2013)
ORDER Denying 251 MOTION to Preclude, filed by Par Pharmaceutical Inc.. Signed by Judge Richard G. Andrews on 8/16/2013. (nms) (Entered: 08/16/2013)
Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding LiveNote. (Silver, Daniel) (Entered: 08/20/2013)
NOTICE OF SERVICE of Stipulation by 3M Company to the Authenticity of Documents and Things Produced in this Matter; Certification Pursuant to Fed. R. Evid. 902(11) (executed by Peter McArdle); Certification Pursuant to Fed. R. Evid. 902(11) and 902(12) (executed by Dr. Patrick Mohr); Certification Pursuant to Fed. R. Evid. 902(11) and 902(12) (executed by Celine Simonin); and Certification Pursuant to Fed. R. Evid. 902(11) (executed by David Briscoe) by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/20/2013)
NOTICE of Withdrawal of Appearance of Erika R. Caesar and Appearance of James L. Higgins by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Higgins, James) (Entered: 08/20/2013)
NOTICE to Take Deposition of DR. GRAHAM BUCKTON on August 23, 2013 by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/20/2013)
Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. responding to 280 August 22, 2013 letter. (Silver, Daniel) Modified on 8/22/2013 (nms). (Entered: 08/22/2013)
NOTICE OF SERVICE of Certification Pursuant to Fed. R. Evid. 902(11) of Scott Gochnour and Certification Pursuant to Fed. R. Evid. 902(11) of Janie Gwinn by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc..(Vrana, Robert) (Entered: 08/24/2013)
NOTICE of Name Change of Defendant Watson Pharma, Inc. to Actavis Pharma, Inc. by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Vrana, Robert) (Entered: 08/24/2013)
Supplemental Disclosure Statement pursuant to Rule 7.1 filed by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. identifying Corporate Parent Actavis Inc. for Watson Pharma Inc... (Vrana, Robert) (Entered: 08/24/2013)
[SEALED] Stipulation to Stay Litigation, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 8/26/2013 (nms). (Entered: 08/25/2013)
NOTICE of Appearance of Lisa Barons Pensabene by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Silver, Daniel) (Entered: 08/26/2013)
[SEALED] ORDER re 291 Stipulation filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 8/26/2013. (ksr, ) (Entered: 08/26/2013)
REDACTED VERSION of 270 Reply Brief, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 8/27/2013 (nms). (Entered: 08/26/2013)
REDACTED VERSION of 284 Letter by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 08/28/2013)
REDACTED VERSION of 278 Letter, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Higgins, James) Modified on 8/30/2013 (nms). (Entered: 08/30/2013)
REDACTED VERSION of 291 Stipulation by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/04/2013)
REDACTED VERSION of 296 Letter by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 09/04/2013)
Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding exhibits admitted into evidence at trial. (Silver, Daniel) (Entered: 09/06/2013)
STIPULATION And Order Concering Post-Trial Briefing by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/06/2013)
SEALED Official Transcript of Bench Trial (1st Day) held on 08-26-13 before Judge Richard G. Andrewws. Court Reporter/Transcriber Valerie Gunning. (lad) Modified on 11/5/2013 (nms). (Entered: 09/23/2013)
SEALED Official Transcript of Bench Trial (2nd Day) held on 08-27-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather Triozzi. (lad) Modified on 11/5/2013 (nms). (Entered: 09/23/2013)
SEALED Official Transcript of Bench Trial (3rd Day) held on 08-28-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Valerie Gunning. (lad) Modified on 11/5/2013 (nms). (Entered: 09/23/2013)
SEALED Official Transcript of Bench Trial (4th Day) held on 08-29-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Valerie Gunning. (lad) Modified on 11/5/2013 (nms). (Entered: 09/23/2013)
Opening Post-Trial Brief on Invalidity, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 9/30/2013 (nms). (Entered: 09/27/2013)
NOTICE of Intent to Request Redaction by Robert M. Vrana re 306 Transcript,, 309 Transcript,, 308 Transcript,, 307 Transcript,,. (Vrana, Robert) (Entered: 09/30/2013)
REDACTED VERSION of 310 POST Trial Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 10/04/2013)
Letter to The Honorable Richard G. Andrews from Robert M. Vrana advising that Plaintiffs do not oppose 314 Motion to Redact Trial Transcripts. (Vrana, Robert) Modified on 10/16/2013 (nms). (Entered: 10/16/2013)
REDACTED VERSION of 314 MOTION to Redact Trial Transcripts, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 10/22/2013 (nms). (Entered: 10/21/2013)
POST TRIAL Answering Brief Concerning Validity, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 10/28/2013 (nms). (Entered: 10/25/2013)
REDACTED VERSION of 318 POST Trial Brief, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 11/1/2013 (nms). (Entered: 11/01/2013)
ORDER Granting 314 MOTION to Redact Trial Transcripts. Signed by Judge Richard G. Andrews on 11/5/2013. (nms) (Entered: 11/05/2013)
Official Transcript of hearing held on August 19, 2013 before Judge Andrews. Court Reporter/Transcriber Valerie Gunning,Telephone number (302) 573-6194. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/27/2013. Redacted Transcript Deadline set for 12/9/2013. Release of Transcript Restriction set for 2/4/2014. (vjg) (Entered: 11/06/2013)
Post-Trial Reply Brief on Invalidity, by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) Modified on 11/12/2013 (nms). (Entered: 11/08/2013)
REDACTED VERSION of 322 POST Reply Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 11/18/2013 (nms). (Entered: 11/15/2013)
Letter to The Honorable Richard G. Andrews from Steven J. Fineman regarding lifting the stay and potential trial dates - re 293 Order,. (Fineman, Steven) (Entered: 11/19/2013)
Letter to Judge Andrews from Melanie K. Sharp, Esq. regarding enclosing disk containing electronic versions of Watson Defendants post-trial briefs and related exhibits. (Sharp, Melanie) (Entered: 11/22/2013)
Letter to The Honorable Richard G. Andrews from Daniel M. Silver regarding Enclosing Disks Containing Plaintiffs Post-Trial Briefing with Hyperlinks to Exhibits, Transcripts, Cases and Statutes Cited Therein. (Silver, Daniel) (Entered: 11/22/2013)
STIPULATION TO EXTEND TIME Plaintiffs Opposition to Watsons Motion to Deconsolidate Cases to Thursday, January 9, 2014 - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 12/20/2013)
STIPULATION TO EXTEND TIME to Respond to Watsons Motion to Deconsolidate Cases to January 9, 2014 - filed by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 12/20/2013)
RESPONSE to 328 Motion to Deconsolidate Cases, filed by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 1/9/2014 (nms). (Entered: 01/09/2014)
[SEALED] OPENING BRIEF in Support re 333 MOTION for Sanctions filed by Par Pharmaceutical Inc..Answering Brief/Response due date per Local Rules is 1/27/2014. (Fineman, Steven) (Entered: 01/10/2014)
[SEALED] DECLARATION of David H. Silverstein re 333 MOTION for Sanctions, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 1/13/2014 (nms). (Entered: 01/10/2014)
STIPULATION TO EXTEND TIME Deadline for Watson to file its Reply in Support of Motion to Deconsolidate Cases to January 28, 2014 - filed by Actavis, Inc., LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Par Pharmaceutical Inc., Par Pharmaceutical Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 01/14/2014)
REDACTED VERSION of 334 Opening Brief in Support, by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 1/21/2014 (nms). (Entered: 01/17/2014)
REDACTED VERSION of 335 Declaration of David H. Silverstein, by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 1/21/2014 (nms). (Entered: 01/17/2014)
STIPULATION TO EXTEND TIME Deadline for Watson to file its Reply in Support of Motion to Deconsolidate Cases to February 10, 2014 - filed by Actavis, Inc., LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Par Pharmaceutical Inc., Par Pharmaceutical Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 01/27/2014)
REDACTED VERSION of 345 Answering Brief in Opposition, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 02/03/2014)
REDACTED VERSION of 346 Declaration, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 02/03/2014)
Official Transcript of Scheduling Conference held on 12-18-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather Triozzi. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 2/27/2014. Redacted Transcript Deadline set for 3/10/2014. Release of Transcript Restriction set for 5/7/2014. (lad) (Entered: 02/06/2014)
[SEALED] REPLY BRIEF re 333 MOTION for Sanctions filed by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 02/06/2014)
STIPULATION TO EXTEND TIME for Watson to File its Reply in Support of Motion to Deconsolidate Cases to February 19, 2014 - filed by Actavis, Inc., LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Par Pharmaceutical Inc., Par Pharmaceutical Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 02/10/2014)
REDACTED VERSION of 352 Reply Brief, by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 2/18/2014 (nms). (Entered: 02/14/2014)
REDACTED VERSION of 353 Declaration of Jennifer Koh, by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 2/18/2014 (nms). (Entered: 02/14/2014)
STIPULATION TO EXTEND TIME for Watson to file its Reply in Support of Motion to Deconsolidate cases to March 10, 2014 - filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 02/19/2014)
STIPULATION TO EXTEND TIME Plaintiffs to File a Motion Seeking to Seal Portions of the December 18, 2013 Conference Transcript (D.I. 351) to Thursday, March 6, 2014 (from Thursday, February 27, 2014) - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 02/27/2014)
ORDER Denying 359 Unopposed Motion to Seal Limited Portions of the Transcript from the December 18, 2013, Conference, filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 3/10/2014. (nms) (Entered: 03/10/2014)
STIPULATION TO EXTEND TIME for Watson to File its Reply in Support of Motion to Deconsolidate Cases (D.I. 328) to March 27, 2014 - filed by Actavis, Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Vrana, Robert) (Entered: 03/10/2014)
NOTICE OF SERVICE of Plaintiffs Fifth Supplemental Response to Pars Interrogatory No.2 filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 03/13/2014)
NOTICE OF SERVICE of Par Pharmaceutical, Inc.s Rebuttal Expert Report of Professor Graham Buckton filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 03/21/2014)
MEMORANDUM OPINION re 333 MOTION for Sanctions. Signed by Judge Richard G. Andrews on 3/26/2014. (nms) (Entered: 03/26/2014)
ORDER Denying 333 MOTION for Sanctions. Signed by Judge Richard G. Andrews on 3/26/2014. (nms) (Entered: 03/26/2014)
NOTICE OF SERVICE of Plaintiffs Supplemental Reply Expert Report of Professor Martyn C. Davies filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 03/26/2014)
ORDER Providing a schedule for preparing and filing the pretrial order (see Order for further details). Signed by Judge Richard G. Andrews on 3/26/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 03/26/2014)
REPLY BRIEF re 328 Motion to Deconsolidate Cases filed by Actavis, Inc., Watson Laboratories Inc.. (Vrana, Robert) (Entered: 03/27/2014)
NOTICE of Withdrawal of Certain Counsel Admitted Pro Hac Vice by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Silver, Daniel) (Entered: 04/09/2014)
ORDER After Pretrial Conference (see Order for further details). Signed by Judge Richard G. Andrews on 4/21/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 04/21/2014)
[SEALED] Letter to The Honorable Richard G. Andrews from Steven J. Fineman regarding Defendants response to Courts Instructions at April 18, 2014 Pretrial Conference. (Fineman, Steven) (Entered: 04/24/2014)
Letter to The Honorable Richard G. Andrews from Steven J. Fineman regarding discovery dispute conference scheduled for April 29, 2014. (Fineman, Steven) (Entered: 04/28/2014)
REDACTED VERSION of (41 in 1:13-cv-01467-RGA, 376 in 1:11-cv-01077-RGA) Letter, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 04/29/2014)
ORDER Denying Plaintiff Novartis Pharmaceuticals Corporations request to rely on limited designations of the deposition testimony of Pars expert, Dr. Arthur Kibbe, at the May 1-2, 2014, trial. Signed by Judge Richard G. Andrews on 4/30/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 04/30/2014)
REDACTED VERSION of (378 in 1:11-cv-01077-RGA, 43 in 1:13-cv-01467-RGA) Letter to The Honorable Richard G. Andrews by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 04/30/2014)
Official Transcript of Discovery Dispute held on 04-29-14 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/22/2014. Redacted Transcript Deadline set for 6/2/2014. Release of Transcript Restriction set for 7/30/2014. (lad) (Entered: 05/01/2014)
Witness List for Bench Trial held 5/1/2014 - 5/2/2014. (ksr, ) (Entered: 05/02/2014)
NOTICE requesting Clerk to remove Gina R. Gencarelli as co-counsel. Reason for request: no longer with the firm. (Lester, Katharine) (Entered: 05/08/2014)
Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq regarding the Enclosure of All Exhibits Admitted into Evidence at Trial. (Silver, Daniel) (Entered: 05/09/2014)
Exhibit List from Bench Trial held 5/1/2014 - 5/2/2014. (ksr, ) (Entered: 05/12/2014)
STIPULATION and Order Concerning Post-Trial Briefing, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 5/13/2014 (nms). (Entered: 05/13/2014)
SO ORDERED Granting (55 in 1:13-cv-01467-RGA, 396 in 1:11-cv-01077-RGA) Stipulation and Order Concerning Post-Trial Briefing, filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 5/13/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 05/13/2014)
SEALED Official Transcript of Bench Trial (Day 1) held on 05-01-14 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather Triozzi. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/6/2014. Redacted Transcript Deadline set for 6/16/2014. Release of Transcript Restriction set for 8/14/2014. (lad) Modified on 5/22/2014 (nms). Modified on 5/22/2014 (nms). Modified on 5/23/2014 (nms). (Entered: 05/16/2014)
NOTICE of Intent to Request Redaction by Katharine Crawford Lester re (399 in 1:11-cv-01077-RGA) Transcript, (398 in 1:11-cv-01077-RGA) Transcript,, (Lester, Katharine) (Entered: 05/23/2014)
Opening Post-Trial Brief on Invalidity, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 5/27/2014 (nms). (Entered: 05/23/2014)
NOTICE of of Intent to Redact by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation re (399 in 1:11-cv-01077-RGA) Transcript, (398 in 1:11-cv-01077-RGA) Transcript,, (Silver, Daniel) (Entered: 05/23/2014)
REDACTED VERSION of 403 Post-Trial Brief Concerning Infringement, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 6/2/2014 (nms). (Entered: 05/30/2014)
[SEALED] EXHIBIT A re 406 MOTION to Redact, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 6/10/2014 (nms). (Entered: 06/06/2014)
REDACTED VERSION of 407 Exhibit A to Motion to Redact, by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 6/13/2014 (nms). (Entered: 06/13/2014)
Answering Post-Trial Brief Concerning Validity, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 6/16/2014 (nms). (Entered: 06/13/2014)
[SEALED] Responsive Post-Trial Brief on Non-Infringement, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 6/16/2014 (nms). (Entered: 06/13/2014)
ORDER Granting (D.I. 406 in 1:11-cv-01077-RGA, D.I. 63 in 1:13-cv-01467-RGA) Unopposed Motion to Redact Transcript, filed by Par Pharmaceutical Inc.. Signed by Judge Richard G. Andrews on 6/13/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 06/16/2014)
REDACTED VERSION of 398 Transcript - Bench Trial Day 1. (nms) (Entered: 06/16/2014)
REDACTED VERSION of 399 Transcript - Bench Trial Day 2. (nms) (Entered: 06/16/2014)
TRIAL OPINION (*Novartis should submit an agreed upon form of final judgment within two weeks). Signed by Judge Richard G. Andrews on 6/18/2014. Associated Cases: 1:11-cv-01077-RGA, 1:11-cv-01112-RGA(nms) (Main Document 414 replaced on 6/18/2014) (nms). (Entered: 06/18/2014)
ORDER Granting Motion to Deconsolidate Cases (D.I. 328 in 11-cv-01077-RGA), filed by Actavis, Inc.. Signed by Judge Richard G. Andrews on 6/18/2014. Associated Cases: 1:11-cv-01077-RGA, 1:11-cv-01112-RGA(nms) (Entered: 06/18/2014)
REDACTED VERSION of 410 POST Trial Brief on Non-Infringement, by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 6/20/2014 (nms). (Entered: 06/20/2014)
Reply Post-Trial Brief On Invalidity, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 6/23/2014 (nms). (Entered: 06/20/2014)
REDACTED VERSION of 417 POST Trial Brief, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 6/25/2014 (nms). (Entered: 06/25/2014)
Letter to The Honorable Richard G. Andrews from Steven J. Fineman regarding enclosure of two disks containing Defendant Par Pharmaceutical, Inc.s post-trial briefs. (Fineman, Steven) (Entered: 06/27/2014)
Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding the Enclosure of Two Disks Containing Plaintiffs Post-Trial Briefs. (Silver, Daniel) (Entered: 06/27/2014)
[SEALED] Response to 422 Notice of Subsequent Authority In Support of Its Post-Trial Briefing on Invalidity, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/31/2014 (nms). (Entered: 07/31/2014)
CERTIFICATE OF SERVICE of Plaintiffs Response to Par Pharmaceutical, Inc.s Notice of Subsequent Authority In Support of Its Post-Trial Briefing on Invalidity by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation re (423 in 1:11-cv-01077-RGA) Notice (Other), (Silver, Daniel) (Entered: 07/31/2014)
REDACTED VERSION of 423 Response to Par Pharmaceutical, Inc.s Notice of Subsequent Authority, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 8/7/2014 (nms). (Entered: 08/07/2014)
TRIAL OPINION for the Bench Trial held on May 1 and 2, 2014. Novartis did not prove that Pars ANDA products infringe claim 7 of the 031 patent. Par should submit an agreed upon form of final judgment within two weeks. Signed by Judge Richard G. Andrews on 8/29/2014. (nms) (Entered: 09/02/2014)
STIPULATION TO EXTEND TIME to Submit Proposed Final Judgment to September 16, 2014 - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/12/2014)
FINAL JUDGMENT (CASE CLOSED). Signed by Judge Richard G. Andrews on 9/17/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-01467-RGA(nms) (Entered: 09/17/2014)
Timeline
filed_date
closed_date
Nov
Dec
2012
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2013
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2014
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Patents In Case

Not a member? Sign up for free!